Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Akeso Biopharma Inc (9926 HK)
Watchlist
164
Analysis
Health Care
•
China
Akeso Inc. operates operatesa s a biotech company. The compnay develops treatments and therapies for various types of diseases. Akeso serves cutomers worldwide
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Akeso Biopharma Inc
•
16 Apr 2024 23:56
[Blue Lotus Healthcare Sector Update]: Bottom-Fishing at the Bottom of the Business Cycle
Liquidity crises in healthcare innovation present buying opportunity;PD-1 exceeds expectations with 20%YoY growth forecast for 2024;Biosimilars...
Blue Lotus Research Institute
Follow
191 Views
Share
bullish
•
Akeso Biopharma Inc
•
09 Apr 2024 20:04
•
Broker
Akeso (9926 HK) - Promising Ph3 Data of Cadonilimab in 1L GC
Promising Ph3 data of cadonilimab in 1L GC, especially for patients with low PD-L1 expression. The interim Ph3 (NCT05008783) data of cadonilimab in...
CMB International
Follow
287 Views
Share
bullish
•
Akeso Biopharma Inc
•
20 Mar 2024 20:05
Akeso Biopharma Placement (9926.HK) - Would Investors Be Willing to Take a Gamble?
Akeso's valuation has somewhat priced in the success of AK112’s head-to-head trial with KEYTRUDA.But if AK112 fails in critical trials, it will...
Xinyao (Criss) Wang
Follow
393 Views
Share
bullish
•
Akeso Biopharma Inc
•
20 Mar 2024 18:39
Akeso Inc Placement - A Small One to Digest, Momentum Has Been Strong
Akeso Biopharma Inc (9926 HK) is looking to raise US$155m from its primary placement. Representing 5.7 days of its three month ADV, the deal would...
Clarence Chu
Follow
354 Views
Share
bullish
•
Akeso Biopharma Inc
•
20 Mar 2024 18:37
•
Broker
Akeso (9926 HK) - Expect Another Fruitful Year in 2024
In FY23, Akeso recorded RMB4.53bn in revenue, including RMB1.63bn from product sales and RMB2.92bn from license income relevant to AK112 (PD1/VEGF).
CMB International
Follow
177 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.1
x